Access
To read this story in full you will need to login or make a payment (see right).
Brief Communication
Nature Medicine 10, 484 - 486 (2004)
Published online: 18 April 2004 | doi:10.1038/nm1042
The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
Davide Ruggero1,2,4, Lorenzo Montanaro1,2, Li Ma1,2, Wei Xu1,2, Paola Londei3, Carlos Cordon-Cardo2 & Pier Paolo Pandolfi1,2
Abstract
The mammalian target of rapamycin, mTOR, regulates cell growth and proliferation. Here we show that the initiation factor of translation (eIF-4E), a downstream effector of mTOR, has oncogenic effects in vivo and cooperates with c-Myc in B-cell lymphomagenesis. We found that c-Myc overrides eIF-4E-induced cellular senescence, whereas eIF-4E antagonizes c-Myc-dependent apoptosis in vivo. Our results implicate activation of eIF-4E as a key event in oncogenic transformation by phosphoinositide-3 kinase and Akt.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapyNature Letters to Editor (18 Mar 2004)
AGC kinases regulate phosphorylation and activation of eukaryotic translation initiation factor 4BOncogene Original Article
Regulation of cyclin D1 expression by mTORC1 signaling requires eukaryotic initiation factor 4E-binding protein 1Oncogene Original Article
See all 22 matches for Research